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ARTICLE
Cholinergic neural activity directs retinal
layer-specific angiogenesis and blood retinal
barrier formation
G.A. Weiner 1,2,6, S.H. Shah 1,2,3,6, C.M. Angelopoulos4, A.B. Bartakova5, R.S. Pulido4, A. Murphy 4,
E. Nudleman5, R. Daneman4,7 & J.L. Goldberg3,5,7
Blood vessels in the central nervous system (CNS) develop unique features, but the
contribution of CNS neurons to regulating those features is not fully understood. We report
that inhibiting spontaneous cholinergic activity or reducing starburst amacrine cell numbers
prevents invasion of endothelial cells into the deep layers of the retina and causes blood-
retinal-barrier (BRB) dysfunction in mice. Vascular endothelial growth factor (VEGF), which
drives angiogenesis, and Norrin, a Wnt ligand that induces BRB properties, are decreased
after activity blockade. Exogenous VEGF restores vessel growth but not BRB function,
whereas stabilizing beta-catenin in endothelial cells rescues BRB dysfunction but not vessel
formation. We further identify that inhibiting cholinergic activity reduces angiogenesis during
oxygen-induced retinopathy. Our findings demonstrate that neural activity lies upstream of
VEGF and Norrin, coordinating angiogenesis and BRB formation. Neural activity originating
from specific neural circuits may be a general mechanism for driving regional angiogenesis
and barrier formation across CNS development.
https://doi.org/10.1038/s41467-019-10219-8 OPEN
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B lood vessels in the CNS have unique properties not foundin peripheral vasculature. Many of these properties, such asthe set of functions known as the blood–brain barrier (BBB)
or blood–retinal barrier (BRB), localize to central nervous system
(CNS) endothelial cells (ECs)1,2. CNS ECs lack fenestrations, have
tight junctions, and form close associations with processes from
brain parenchymal cells like microglia, pericytes, astrocytes, and
neurons3,4. Microglia5,6, pericytes7, and astrocytes8,9 contribute
to the function of the BBB and the patterning of blood vessels
during development. Some studies have suggested that altering
neural activity can have small effects on vascular patterning in the
cortex, but the role of neurons, and neural activity, in the
development and maintenance of CNS vascular properties has
not been decisively established10–13.
In the postnatal mouse retina, waves of spontaneous neural
activity mediated by a succession of neural circuits occur con-
temporaneously14 with layer-specific angiogenesis (Fig. 1a)15. A
period of cholinergic neural activity (P0–P10) driven by starburst
amacrine cell (SAC) homotypic connections and heterotypic
connections to retinal ganglion cells (RGCs) overlaps with the
development of the superficial and deep retinal vascular plexuses.
SACs are the only cholinergic neuron in the retina16. Sponta-
neous correlated SAC activity is known to play a role in the
refinement of intraretinal synaptic connections14,17 and eye-
specific segregation in the lateral geniculate nucleus18,19, but no
role in vascular development has been described. However,
angiogenesis is thought to be driven by the relative hypoxic
demand induced by tissue metabolism20. Since neural tissue
accounts for a disproportionate amount of energy utilization in
the body21,22, we asked whether the activity of specific neurons or
circuits contribute to compartment-specific angiogenesis and
BRB formation.
Results
A targeted toxin reduces SAC number and inhibits deep-layer
angiogenesis. Anti-ChAT-SAP is a targeted toxin that selectively
kills cholinergic neurons in multiple CNS regions23–26. In the
retina, ChAT-conjugated toxins reduce SACs and block choli-
nergic retinal waves27,28, but do not affect the architecture of
bipolar cell projections29. We reduced SACs by about 40%
without affecting RGC or bipolar cell numbers (Supplementary
Fig. S1A–D) by intravitreal injection of anti-ChAT-SAP at P3 and
measured the extent of the superficial and deep vascular plexuses
at P9 by confocal imaging (Fig. 1b, c). After SAC reduction there
was a substantial reduction in deep-layer vasculature at P9
(Fig. 1d), which normally covers nearly 50% of the retinal area at
this developmental age, although single vessels were occasionally
present. SAC reduction did not inhibit growth of the superficial
layer (Fig. 1d), which is also developing from P0 to P9, nor did
SAC reduction at P11 inhibit the growth of the middle layer
(Fig. 1e–g), which develops from P11 to P15 during a phase of
glutamatergic retinal waves. Thus SAC reduction specifically
inhibits angiogenesis of deep-layer vessels during the period of
cholinergic waves.
Cholinergic blockade specifically prevents deep-layer angio-
genesis. SACs generate spontaneous activity by homotypic con-
nections to other SACs and heterotypic connections onto a subset
of RGCs30. Reducing SACs ablates retinal waves but does not
affect the overall electrical activity of RGCs28. We sought to
clarify the role of RGC activity versus SAC activity using phar-
macological inhibitors. Tetrodotoxin (TTX) inhibits RGC action
potentials but does not affect propagating cholinergic retinal
waves31. Epibatidine (EPI) desensitizes nicotinic cholinergic
receptors (nAChRs) on both SACs and RGCs and is well-known
to block cholinergic waves32–39, allowing the independent effect
of RGC action potentials and SAC activity to be established. The
glutamate analog 2-amino-4-phosphonobutyrate (APB) blocks
the later-appearing glutamatergic waves, and does not have any
effect on cholinergic waves40–42. EPI had the same effect on
vascular development as SAC reduction, substantially reducing
deep-layer formation when injected from P3 to P9 (Fig. 1b–d),
but had no effect on superficial layer formation, and no effect on
middle layer formation from P11 to P15 (Fig. 1e–g). TTX had no
effect on vascular development (Fig. 1b–g) suggesting the specific
activity of SACs conferred this effect. APB also had no effect
(Fig. 1b–g) from P3 to P9, further supporting the specific role of
cholinergic activity in driving angiogenesis from P3 to P9 and
consistent with the prior data on SAC reduction and consistent
with the switch from cholinergic to glutamatergic waves during
this later period of development.
To further address the role of SACs neural activity, we
expressed the inhibitory designer receptor exclusively activated by
designer drugs (Gi-DREADD) in SACs using the ChAT promoter
(Supplementary Fig. S3A). Systemic administration of CNO from
P3 to P9 decreased deep-layer angiogenesis, but had no effect on
middle layer angiogenesis from P11 to P15 (Supplementary
Fig. S3B–D). Thus SAC activity is required for normal
vascularization of the deep retinal vascular layer, but not the
superficial layer.
BRB function is compromised after cholinergic disruption. We
investigated the function of the BRB as measured by NHS–biotin
permeability under the same sets of conditions: SAC reduction,
pharmacological blockade of cholinergic activity, and chemoge-
netic inhibition of SACs from P3 to P9 and P11 to P15. SAC
reduction, EPI injection and Gi-DREADD activation in SACs led
to increased barrier permeability at P9, but not at P15 or with
TTX (Fig. 2a, b, Supplementary Fig. S3E), indicating that SAC
activity is required for regulating BRB properties only during the
period of cholinergic waves. Increased barrier permeability can be
secondary to retinal hemorrhage, but no extravascular red blood
cells (RBCs) were observed after EPI injection, although there was
an increase in the number of intravascular RBCs remaining after
transcardial perfusion (Fig. 2c). Along with the observed central
distribution of NHS–biotin leakage, this suggests that even the
superficial layer vessels in EPI-injected retinas are not well-
perfused by the circulatory system. To determine why there was
increased BRB permeability we examined the expression of
claudin-5 (Cldn5), which is critical to form the paracellular
barrier between endothelial cells43. Expression of Cldn5 was
disrupted after EPI injection as evidenced by gaps in the normally
smooth junctional strands, and by areas of Cldn5-negative vessels
(Fig. 2e, f). EPI injection did not alter Cav1 or Plvap expression
(Supplementary Fig. S6).
Neural activity regulates angiogenic and barriergenic signaling.
Together, defective angiogenesis and barriergenesis after inhibi-
tion of SAC activity led us to hypothesize that pro-angiogenic and
pro-barriergenic signaling may be decreased in the retina after
SAC blockade. Vascular endothelial growth factor (VEGF) is
known to be important in developmental and pathological
angiogenesis44. Wnt signaling, mediated by Muller glia-derived
Norrin, has been shown to be important for both retinal angio-
genesis and BRB barriergenesis45,46. The BRB is comprised of
multiple functions, many of which have been shown to be Wnt-
dependent45–52.Vasculature restricted to the superficial vascular
plexus and Cldn5 dysregulation are features observed in Norrin
knockout mice53. We tested whether inhibition of SAC activity
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Fig. 1 Inhibition of SAC activity selectively inhibits deep vascular plexus formation. a Neural circuit-specific activity overlaps with layer-specific
angiogenesis in the developing mouse retina. b Schematic of the confocal imaging strategy for BSL-stained retinas. Confocal stacks taken at P9 were color-
coded for depth so that the superficial layer is blue, penetrating vessels are green, and deep-layer vessels are red. c Anti-ChAT-SAP was injected
intravitreally at P3 and pharmacologic inhibitors (EPI, APB, and TTX) were injected intravitreally at P3, P5, and P7 and the retinas were analyzed at P9.
Scale bar is 200 µm. d The deep and superficial layers develop radially from the optic nerve head (ONH) and thus were quantified as the percentage of
retinal surface area covered by each vascular layer. EPI and ChAT-SAP injected retinas both demonstrate a lack of deep-layer vasculature not observed in
APB- or TTX-injected eyes or in control eyes (IgG-SAP and PBS). e Schematic of the strategy for isolating the middle layer by confocal imaging of
BSL-stained retinas at P15. f Anti-ChAT-SAP was injected intravitreally at P11 and pharmacologic inhibitors (EPI, APB, and TTX) were injected intravitreally
at P11 and P13, and the retinas were analyzed at P15. g The middle vascular layer develops contemporaneously at all retinal eccentricites, and thus was
quantified by sampling an area near the ONH and measuring the linear amount of vessels in the middle layer per unit area of retina. None of the injected
compounds had any effect on middle layer development. Scale bar is 50 µm. Statistical tests are Student’s t tests, two-tailed, paired when comparing
control and treated eyes from the same animal, otherwise assuming unequal variances. In d, g, individual data points are plotted, dashed line is the mean,
gray box is the 95% confidence interval, number of retinas analyzed is in parentheses, and all other comparisons were not significant. Number of
independent samples in each group is in parentheses under the X-axis data label. Bandeiraea simplicifolia lectin I (BSL) staining was used to visualize
vessels
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10219-8 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2477 | https://doi.org/10.1038/s41467-019-10219-8 | www.nature.com/naturecommunications 3
affected the expression of VEGF and Norrin, and found both
were decreased (Fig. 3a).
VEGF can increase vascular permeability and drive angiogen-
esis and Norrin can decrease vascular permeability and is also
required for retinal-specific angiogenesis53,54. We next sought to
clarify the contribution of VEGF and Norrin to the vascular
abnormalities observed after inhibition of cholinergic activity.
VEGF was co-injected with EPI and found to restore some deep-
layer angiogenesis (Fig. 3b, c), but did not have any additional
effect on increasing the permeability of the BRB (Fig. 3d, e),
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suggesting that EPI alone fully permeabilizes the BRB. To
determine the role of Norrin/beta-catenin signaling, we expressed
a stabilized form of beta-catenin (BGOF) under the control of the
vascular endothelial cadherin promoter (VECdh-CreERT2). We
also injected lithium chloride (LiCl) systemically, which has been
shown to stabilize beta-catenin via inhibition of glycogen
synthase kinase 3 beta (GSK3beta)55. Neither BGOF nor LiCl
increased deep vascular plexus growth (Fig. 3b, c), but both
prevented the increase in BRB permeability after inhibition of
SAC activity (Fig. 3d, e). Together, these data show that VEGF
and Norrin are the critical limiting factors for angiogenesis and
barriergenesis respectively, in the context of SAC activity
blockade.
Inhibition of cholinergic activity reduces pathological neo-
vascularization. We next asked whether similar activity-
dependent angiogenesis and barriergenesis is disrupted in a dis-
ease model of the developing retinal vasculature. Retinopathy of
prematurity (ROP) is a disease that afflicts premature infants
subject to the high oxygen concentrations needed to sustain blood
O2 saturation. A common feature of ROP as well as other reti-
nopathies of adulthood diseases is the presence of abnormal
neoangiogenic vessels that leak, hemorrhage, and physically dis-
tort the retina, leading to loss of vision. We asked whether cho-
linergic signaling plays a role in pathological neovascularization
observed during ROP and tested this hypothesis using the
oxygen-induced retinopathy (OIR) mouse model of ROP56.
Inhibiting SACs during the neovascular phase from P12 to P17
(Fig. 4a) with intravitreal EPI injections decreased the area of
vaso-obliteration (VO, Fig. 4b), the amount of neovascularization
(Fig. 4b), and the amount of hemorrhage in the retina (Fig. 4d, e).
This demonstrates that cholinergic signaling is a critical compo-
nent driving pathogenic retinal neoangiogenesis.
Discussion
In summary, these data point to three important conclusions.
First, neural activity derived from a specific circuit underlies both
regional angiogenic drive and barrier formation in this CNS
vasculature. Although the metabolism of neural tissue may
account for a disproportionate amount of total body energy uti-
lization, several aspects of this work shed further light on the
relationship between specific neural activity and angiogenesis. In
particular, it is not generic basal metabolism of neurons but
rather the synaptic and downstream activity originating from a
specific neural subtype during a select period of retinal develop-
ment that drives oxygen consumption, angiogenesis, and bar-
riergenesis. SACs may be well positioned to account for
significant energy utilization in the retina as their dendritic fields
overlap more extensively than those of other retinal neurons57,
and dendrites contribute more than other neural compartments
to metabolic demand58. In fact, we observed that SAC activity
and retinal activity driven by SACs accounts for nearly 50% of
retinal oxygen consumption in early postnatal isolated retinas
(Fig. S3F, G). Because the effect of EPI on cholinergic activity is
transient, the inhibition of angiogenesis was transient; eyes
injected with EPI from P3 to P9 subsequently recovered the
normal trilaminar vascular network by P21 (Fig. S2D). This is
consistent with prior observations that EPI-induced inhibition of
cholinergic waves is transient, with resumption of cholinergic
waves after blockade is lifted, and subsequent delayed initiation of
the late phase glutamatergic waves59. Thus neural activity may be
a generic stimulus for triggering angiogenesis in the CNS, but this
dependence may be restricted to specific circuits and CNS regions
at different periods in development.
Second, these data show that neural activity lies upstream of
pro-angiogenic and probarriergenic signaling, and temporally
coordinates the action of these pathways. VEGF and Wnt are
both required for CNS angiogenesis54, and Wnt specifically for
BRB function60 but the independent contributions of each to
vessel formation and barrier induction are not understood.
Analysis of knockout animals is complicated by the fact that
VEGF is increased after Norrin knockout in mice61. These ani-
mals have a disrupted BRB, but is it because EC’s lack Wnt
signaling or because VEGF is increased? Here we show the
functions of VEGF and Norrin are uncoupled in the context of
diminished developmental neural activity such that VEGF con-
trols vascular outgrowth and Norrin turns on BRB properties.
How might neural activity coordinate such a signal? Prior work
has shown that layer-specific angiogenesis is due to VEGF derived
from specific cell types62. In that case, amacrine and horizontal
cell-derived VEGF drives intermediate plexus formation. How-
ever, it is also known that Muller glia sense neurotransmitter
spillover from amacrine cell synapses63, thus neural activity may
be driving VEGF production in nonneuronal cell types as occurs,
for example, with astrocytes producing the VEGF that drives
superficial layer angiogenesis20. These data further suggest the
intriguing possibility that the microenvironmental cues needed to
guide vessel development are present even without the stimulus of
neural activity necessary to produce the pro-angiogenic factors.
Third, we have implicated a role for cholinergic signaling in
pathological neoangiogenesis that occurs in vascular retinopathies.
We studied this question in OIR and found that cholinergic blockade
reduced neovascularization. This implicates cholinergic signaling as a
central regulator of angiogenesis in development and disease, though
the source of acetylcholine in OIR is not clearly identified. We
showed that cholinergic blockade inhibits deep-layer angiogenesis, yet
in OIR, neovascularization occurs in the superficial layer. The
mechanism by which normal developmental vascularization and
pathologic neovascularization are related is unclear, but these data
Fig. 2 Inhibition of SAC activity from P3 to P9 leads to breakdown of the blood–retinal–barrier (BRB). a BRB integrity was assessed by perfusing
0.25mg/mL NHS–biotin after SAC reduction and pharmacological inhibition of SAC activity from P3 to P9. Extravascular NHS–biotin was visualized by
streptavidin-AlexaFluor 594 staining, and quantified as the amount of signal outside of the BSL-defined vasculature. Scale bar is 200 µm. b Quantification
of extravascular NHS–biotin accumulation by fluorescence microscopy. Inhibition of SAC activity from P3 to P9, but not P11 to P15 led to increased
extravascular accumulation of NHS–biotin. TTX and APB had no effect on NHS–biotin leakage. c Intraretinal hemorrhage was examined by anti-Ter119
immunostaining, which identifies red blood cells (RBCs). No intraretinal extravascular RBC was observed in any EPI or PBS injected eye. Scale bar is 50 µm.
d Quantification of intravascular RBCs. There was an increase in intravascular RBCs after transcardial perfusion in EPI eyes. A similar effect of anti-ChAT-
SAP was observed (Supplementary Fig. S5). e Cldn5 expression was examined by immunofluorescent staining. Altered Cldn5 expression correlated with
BRB dysfunction after EPI injection. Breaks in continuous Cldn5 junctional strands were observed (middle row, arrow). Hatched box is magnified at right
showing an example of a junctional gap, which was rarely observed in control retinas. Some short vessel segments in EPI eyes had lost Cldn5 expression
completely (bottom row, arrowheads). Scale bar is 15 µm. f EPI treatment increased the number of Cldn5 gaps and the amount of Cldn5-negative
vasculature. In b, statistical tests are Student’s two-tailed t tests, paired for comparing control and treated eyes from the same animal; in d, f statistical tests
are the Mann–Whitney U test. Number of independent samples in each group is in parentheses under the X-axis data label
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suggest that further study of cholinergic activity may help uncouple
these mechanisms. Further work should define the role of cholinergic
signaling and the activity of other neurotransmitter-specific circuits in
neovascular diseases of adulthood, such as wet age-related macular
degeneration and proliferative diabetic retinopathy, as well as inves-
tigate the specific circuits responsible for angiogenesis in different
CNS compartments. Given the range of pharmacological modulators
known to act on receptors and enzymes of the cholinergic pathway,
these results extend this broad category of therapeutics to potential
use in neovascular disease.
Methods
Animals. Wild-type animals were C57/BL6 mice purchased from Envigo.
Homozygous ChAT-IRES-Cre knock-in mice (ChatCre) animals were purchased
from The Jackson Laboratory (strain 006410). Heterozygous R26-LSL-Gi-
DREADD (RGi/+) animals were purchased from The Jackson Laboratory
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the bright basement membrane of preretinal neovascular buds. Zoomed in box shows examples of neovascular buds from the areas indicated by the
hatched boxes. Scale bar is 200 µm. c The number of neovascular buds, total area of neovascularization, and area of vaso-obliteration all decreased after
SAC inhibition, but there was no change in the average size of each neovascular bud (n.s. is not significant). d Intraretinal hemorrhage was visible by
brightfield imaging of freshly dissected retinas, and by anti-Ter119 staining of fixed retinal sections. Scale bar is 200 µm on the left, 50 µm on the right.
e SAC inhibition decreased the number of RBCs in the retina. In c, e, statistical tests are Student’s two-tailed t tests, paired for comparing control and
treated eyes from the same animal. Number of independent samples in each group is in parentheses under the X-axis data label
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(strain 026219). ChatCre homozygotes were crossed to RGi/+ animals, and
littermate R+/+ animals were used as controls. All animal experiments were
performed in accordance with national guidelines and UCSD IACUC guidelines.
Experimental/surgical procedures were performed to minimize animal stress and
the number of animals used.
Statistical methods. Statistical methods are detailed in each figure. In general, for
comparing control and treated retinas from the same animal, paired, two-tailed
Student’s t tests were used to account for batch-to-batch variability between
experiments (images are presented without any contrast enhancement), otherwise a
two-tailed Student’s t test assuming unequal variances was used. For counting
RBCs and quantification of Cldn5 integrity, the Mann–Whitney U test was used.
Number of animals used in the statistical analysis, as well as exact p values for those
tests that reached a significance level of p < 0.05 are reported in each figure.
Inhibition of cholinergic activity. Intravitreal injections were done at P3, P5, and
P7 for experiments during the cholinergic period, or at P11 and P13 for experi-
ments during the glutamatergic period. For the OIR model, injections were done at
P13 and P15. In each case, the injection procedure was similar. Animals were
anesthetized using isoflurane flowing through a rodent facemask. Isoflurane was
1–3%, flow 100mL/min, and the procedure lasted approximately 20 min per ani-
mal. After reflex checks, a small cut was made through the eyelid and the lid pulled
back to expose the eye. After P13 the eyes were typically open and the eyelids did
not need to be cut open. Approximately, 0.5–1.0 uL of solution was injected using
pulled glass micropipettes attached to a picospritzer III in P3–P9 pups, 1.5–2.0 uL
in P11–P15 pups. Typically, 20–40 ms duration pulses at 30 PSI were used, but this
was adjusted as needed to inject the appropriate amount. The needle was left in the
eye for 30 s after injection and withdrawn slowly to minimize leakage. The eyelid
was sutured for P3–P9 animals and covered with antibiotic ointment for animals at
every age. One eye was injected with the experimental compound and the other eye
was injected with a vehicle control. Drug concentrations and vehicles were epi-
batidine (Sigma E1145) 1 mM in phosphate-buffered saline (PBS), APB (Sigma
A1910) 1 mM in PBS, TTX (Tocris 1069) 1 mM in citrate buffer, Rabbit anti-
ChAT-SAP (Advanced Targeting Systems IT-42) 0.12 mg/mL in PBS. The control
for ChAT-SAP was an untargeted Rabbit anti-IgG-SAP (Advanced Targeting
Systems IT-35) 0.12 mg/mL in PBS.
CNO injections. Clozapine-n-oxide was purchased from Tocris (4936) dissolved at
20 mM in sterile water, and stored in the dark at −20 degrees. Prior to injection,
CNO was diluted in sterile saline and injected to a final concentration of 0.5 mg/kg.
Two daily intraperitoneal injections were performed, spaced 12 h apart.
Retina collection for vascular analysis. Pups were killed and the whole eyes were
fixed in 4% PFA in 1× PBS at room temperature for 10min, then transferred to 1× PBS
on ice. The retinas were dissected out and fixed in methanol at −20° overnight.
Retina collection for barrier analysis. Pups were deeply anesthetized using a
ketamine/xylazine mixture and then sequentially transcardially perfused with
~10–15 mL of 0.25 mg/mL EZ-Link Sulfo-NHS–Biotin in PBS and ~10–15 mL of
4% PFA in PBS. The whole eyes were fixed in 4% PFA in 1× PBS at room
temperature for 10 min, then transferred to 1× PBS on ice. The retinas were dis-
sected out and postfixed in 4% PFA for 45 min to 1 h then washed in PBS and
stored in PBS plus azide at 4° in the dark. Results of the NHS–biotin uptake assay
were validated against a sodium fluorescein uptake assay (Supplementary Fig. S4).
Immunofluorescence. Whole-mount fixed retinas were washed in PBS then
blocked for 30 min in 0.2% bovine serum albumin, 5% serum, and 0.3% Triton
X-100, then incubated in primary antibody in blocking buffer overnight at 4° with
gentle rocking. Retinas were then washed in 0.3% Triton X-100 three times, and
incubated with secondary antibodies in 0.3% Triton X-100 for 2–4 h at room
temperature, protected from light with gentle rocking. They were then washed in
0.3% Triton X-100 twice, 1x PBS twice, and then mounted on slides with Prolong
Gold Antifade Reagent. Primary antibodies used were rabbit anti-Cldn5 (Thermo
Fisher Scientific 34-1600, 1:500), goat anti-collagen 4 (SouthernBiotech 1340-08,
1:500), and rat anti-Ter119 (abcam ab91113,1:250). Secondary antibodies used
were goat anti-rabbit Alexa Fluor 488 (Thermo Fisher Scientific A-11034, 1:1000),
goat anti-rat donkey anti-goat Alexa Fluor 488 (Thermo Fisher Scientific A27012,
1:1000), donkey anti-rabbit Alexa Fluor 488 (Thermo Fisher Scientific A-21206,
1:1000), goat anti-rabbit Alexa Fluor 594 (Thermo Fisher Scientific A-11037,
1:1000), and donkey anti-goat Alexa Fluor 594 (Thermo Fisher Scientific A-11058,
1:1000). Bandeiraea simplicifolia lectin (BSL) was biotinylated griffonia simplici-
folia lectin I (Vector Laboratories B-1205, 1:250) or fluorescein conjugated (FL-
1201). Streptavidin was streptavidin conjugated to Alexa Fluor 594 (Thermo Fisher
Scientific S32357, 1:1000).
Confocal and epifluorescence imaging. Confocal imaging was done on a Zeiss
LSM 710. A 20 × /0.8 NA air objective was used. Images were acquired at 1 airy
unit resolution with 4× undersampling of pixels in X–Y and 2× undersampling in
Z. Excitation lasers were 488 nm (for Alexa Fluor 488 and fluorescein iso-
thiocyanate (FITC)), 561 nm (for Alexa Fluor 594), and 633 nm (for Alexa Fluor
647). Emissions were collected as separate tracks over wavelength bands exclusive
with other mutually excited fluorophores. Epifluorescence images were collected on
an Axio Imager D2 (Carl Zeiss) with a 5× Fluor, 0.25 NA or 20× Plan-Apochromat,
0.8 NA objective, using a digital camera (Axiocam HRm, Carl Zeiss). AxioVision
software was used to acquire images; Fiji (ImageJ) and Inkscape were used for
image processing and analysis.
Vascular image analysis. Confocal volumes were stitched using Zeiss’ Zen soft-
ware using a strictness of 0.9. Because the stacks were often not completely flat,
they were then rotated in ImageJ using the TransformJ plugin so the superficial
layer vasculature was in the same plane across every stack in the image. The image
was then depth-coded in ImageJ by coloring the stacks according to Z-position
along a blue–green–red axis. Retinal area was quantified in ImageJ by manually
selecting the extent of the flat mount. Coverage of a vascular layer was quantified
by manually selecting the area of the retina covered by that layer and then dividing
by the whole retinal area. For analyzing the middle layer, a ~425 µm × 425 µm
z-stack was taken ~500 µm away from the center of the retina. Vessels were traced
by hand, skeletonized in ImageJ using the Skeletonize plugin, and analyzed for
length and branch points using the same plugin.
BRB image analysis. Epifluorescence images were acquired by focusing on the
superficial layer vasculature. The whole retina was imaged then stitched together
using the MosaicJ plugin in ImageJ or the Zen Software package. Intravascular
regions were defined by BSL-FITC staining, and used to create a mask of the
NHS–biotin image. The masked NHS–biotin image represents extravascular
NHS–biotin accumulation. To account for differences in absolute brightness of
NHS–biotin brightness from experiment to experiment, the extent of the retina was
defined and the average extravascular NHS–biotin intensity per pixel was divided
by the background (nonretinal) intensity per pixel to yield the extravascular
NHS–biotin in arbitrary units.
Angiogenesis and barrier rescue experiments. Epibatidine was injected to
inhibit cholinergic activity from P3 to P9 as previously described. In wild-type
animals EPI was injected into both eyes. For VEGF rescue, recombinant human
VEGF-165 (R&D Systems, 293-VE-010) dissolved in PBS was co-injected with EPI
in one eye at 38 µg/mL. Total injection volume was the same for both eyes. In
transgenic BGOF animals, EPI was injected as previously described with PBS as
control. At P7 20 µL of 2 mg/mL tamoxifen (Sigma T5648) dissolved in corn oil
was injected intraperitoneally. For LiCl rescue, LiCl (Sigma L7026, 30 mg/kg) or
saline was injected intraperitoneally once per day at P7, P8, and P9.
Measurement of oxygen consumption rate. OCR was measured on a Seahorse
XFe96 Flux Analyzer. One millimetre punches from isolated retinas were placed in
the bottom of Seahorse XFe96 spheroid plates. Dissections and incubations were
done in DMEM 5030 supplemented to 20 mM glucose, 10 mM HEPES, 2 mM
glutamine, and 5 mM pyruvate.
Oxygen-induced retinopathy. At P7 a litter of mice (pups and mom) were
introduced in a sealed Biospherix chamber linked to an oxygen line. The O2 is
brought up to 75%. Mice were observed daily without opening the chamber. At
P12, 5 days later, mice were removed from the chamber and placed back in a
normoxic environment.
Western blots. Eyes from mice were removed after CO2 euthanasia and flash
frozen with liquid nitrogen and stored in −80 °C. After defrosting, the retinas were
dissected and homogenized by sonication in 90 µL of cold ddH20 with cOmplete
Protease Inhibitor cocktail (CO-RO ROCHE) and 10 µL 10× RIPA Lysis Buffer
(20–188 EMD MILLIPORE). Samples were centrifuged at 10,000×g for 10 min at 4
°C, and the supernatants collected. Total protein concentration was determined
using a BCA assay (Pierce BCA Protein Assay Kit 23225). Totally, 30–40 g of
protein was loaded on a 4–20% tris-glycine gel (Thermo Fisher Scientific XP04202)
and transferred to an activated 0.2 µm PVDF membrane for immunoblotting. The
membranes were saturated with TBS 1×, 0.05% Tween-20, and 5% nonfat dry milk
for 1 h at room temperature, then incubated overnight at 4 °C with mouse anti-
Norrin (1:300, R&D Systems MAB3014), mouse anti-VEGF C-1(1:300, Santa Cruz
Biotechnology sc-7269), or rabbit anti-GAPDH (1:2000, Cell Signaling Technology
#2118). All membranes were washed with TBS-Tween between incubations. The
membranes were then saturated with peroxidase-conjugated goat anti-mouse or
anti-rabbit (1:3000, Abcam, ab6789 and ab6721) secondary antibodies for 3 h at
room temperature, and revealed with SuperSignal West Pico Chemiluminescent
Substrate (Thermo Fisher Scientific 34080) and imaged with myECL Imager
(Thermo Fisher Scientific). Secondary only controls were done to ensure that
probing mouse tissue homogenates with an anti-mouse primary did not detect
endogenous IgG. Stripping to ensure equal loading was done with ReBlot Plus
Strong Antibody Stripping Solution (EMD Millipore 2504). All quantifications
were done with ImageJ densitometry analysis.
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BREC proliferation assay. Bovine retinal microvascular endothelial cells (BRECs)
were maintained in fibronectin-coated plates (1 μg/cm2). The growth medium was
low glucose DMEM supplemented with 10% bovine calf serum, 5 ng/ml bFGF and
10 ng/ml hVEGF165. BRECs were seeded in 96-well plates (no coating) in low
glucose DMEM supplemented with 10% bovine CS, 2 mM glutamine, and anti-
biotics (growth medium), at a density of 1000 cells per well in 200 μl volume.
VEGF165 was added at the indicated final concentrations. Cells were incubated
with Alamar Blue for 4 h. Fluorescence was measured at 530 nm excitation
wavelength and 590 nm emission wavelength. The experiments were repeated at
least three times.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request.
Received: 25 July 2018 Accepted: 26 April 2019
References
1. Daneman, R. & Prat, A. The blood-brain barrier. Cold Spring Harb. Perspect.
Biol. 7, a020412 (2015).
2. Zlokovic, B. V. The blood-brain barrier in health and chronic
neurodegenerative disorders. Neuron 57, 178–201 (2008).
3. Aird, W. C. Phenotypic heterogeneity of the endothelium: I. Structure,
function, and mechanisms. Circ. Res. 100, 158–173 (2007).
4. Aird, W. C. Phenotypic heterogeneity of the endothelium: II. Representative
vascular beds. Circ. Res. 100, 174–190 (2007).
5. Persidsky, Y. et al. Microglial and astrocyte chemokines regulate monocyte
migration through the blood-brain barrier in human immunodeficiency virus-
1 encephalitis. Am. J. Pathol. 155, 1599–1611 (1999).
6. Hudson, L. C., Bragg, D. C., Tompkins, M. B. & Meeker, R. B. Astrocytes and
microglia differentially regulate trafficking of lymphocyte subsets across brain
endothelial cells. Brain Res. 1058, 148–160 (2005).
7. Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for
blood-brain barrier integrity during embryogenesis. Nature 468, 562–566
(2010).
8. Janzer, R. C. & Raff, M. C. Astrocytes induce blood–brain barrier properties in
endothelial cells. Nature 325, 253–257 (1987).
9. Tout, S., Chan-Ling, T., Holländer, H. & Stone, J. The role of Müller cells in
the formation of the blood-retinal barrier. Neuroscience 55, 291–301 (1993).
10. Whiteus, C., Freitas, C. & Grutzendler, J. Perturbed neural activity disrupts
cerebral angiogenesis during a postnatal critical period. Nature 505, 407–411
(2014).
11. Lacoste, B. et al. Sensory-related neural activity regulates the structure of
vascular networks in the cerebral cortex. Neuron 83, 1117–1130 (2014).
12. Nishijima, T. et al. Neuronal activity drives localized blood-brain-barrier
transport of serum insulin-like growth factor-I into the CNS. Neuron 67,
834–846 (2010).
13. Sadeghian, H. et al. Spreading depolarizations trigger caveolin-1-dependent
endothelial transcytosis. Ann. Neurol. 84, 409–423 (2018).
14. Bansal, A. et al. Mice lacking specific nicotinic acetylcholine receptor subunits
exhibit dramatically altered spontaneous activity patterns and reveal a limited
role for retinal waves in forming ON and OFF circuits in the inner retina.
J. Neurosci. 20, 7672–7681 (2000).
15. Fruttiger, M. Development of the retinal vasculature. Angiogenesis 10, 77–88
(2007).
16. Famiglietti, E. V. Jr. ‘Starburst’ amacrine cells and cholinergic neurons:
mirror-symmetric ON and OFF amacrine cells of rabbit retina. Brain Res. 261,
138–144 (1983).
17. Firth, S. I., Wang, C.-T. & Feller, M. B. Retinal waves: mechanisms and
function in visual system development. Cell Calcium 37, 425–432 (2005).
18. Grubb, M. S., Rossi, F. M., Changeux, J. P. & Thompson, I. D. Abnormal
functional organization in the dorsal lateral geniculate nucleus of mice lacking
the beta 2 subunit of the nicotinic acetylcholine receptor. Neuron 40,
1161–1172 (2003).
19. Torborg, C. L. & Feller, M. B. Spontaneous patterned retinal activity and the
refinement of retinal projections. Prog. Neurobiol. 76, 213–235 (2005).
20. Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip
cell filopodia. J. Cell Biol. 161, 1163–1177 (2003).
21. Ames, A. 3rd, Li, Y. Y., Heher, E. C. & Kimble, C. R. Energy metabolism of
rabbit retina as related to function: high cost of Na+ transport. J. Neurosci. 12,
840–853 (1992).
22. Attwell, D. & Laughlin, S. B. An energy budget for signaling in the grey matter
of the brain. J. Cereb. Blood Flow. Metab. 21, 1133–1145 (2001).
23. Laplante, F., Lappi, D. A. & Sullivan, R. M. Cholinergic depletion in the
nucleus accumbens: effects on amphetamine response and sensorimotor
gating. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 501–509 (2011).
24. Xu, M. et al. Targeted ablation of cholinergic interneurons in the dorsolateral
striatum produces behavioral manifestations of Tourette syndrome. Proc. Natl
Acad. Sci. USA 112, 893–898 (2015).
25. Aoki, S., Liu, A. W., Zucca, A., Zucca, S. & Wickens, J. R. Role of striatal
cholinergic interneurons in set-shifting in the Rat. J. Neurosci. 35, 9424–9431
(2015).
26. Xiao, H. et al. Selective cholinergic depletion of pedunculopontine tegmental
nucleus aggravates freezing of gait in parkinsonian rats. Neurosci. Lett. 659,
92–98 (2017).
27. Speer, C. M. et al. Eye-specific retinogeniculate segregation proceeds normally
following disruption of patterned spontaneous retinal activity. Neural Dev. 9,
25 (2014).
28. Huberman, A. D. et al. Eye-specific retinogeniculate segregation independent
of normal neuronal activity. Science 300, 994–998 (2003).
29. Gunhan, E., Choudary, P. V., Landerholm, T. E. & Chalupa, L. M. Depletion
of cholinergic amacrine cells by a novel immunotoxin does not perturb the
formation of segregated on and off cone bipolar cell projections. J. Neurosci.
22, 2265–2273 (2002).
30. Ford, K. J. & Feller, M. B. Assembly and disassembly of a retinal cholinergic
network. Vis. Neurosci. 29, 61–71 (2012).
31. Stellwagen, D., Shatz, C. J. & Feller, M. B. Dynamics of retinal waves are
controlled by cyclic AMP. Neuron 24, 673–685 (1999).
32. Sun, C., Speer, C. M., Wang, G.-Y., Chapman, B. & Chalupa, L. M. Epibatidine
application in vitro blocks retinal waves without silencing all retinal ganglion
cell action potentials in developing retina of the mouse and ferret. J.
Neurophysiol. 100, 3253–3263 (2008).
33. Feller, M. B., Wellis, D. P., Stellwagen, D., Werblin, F. S. & Shatz, C. J.
Requirement for cholinergic synaptic transmission in the propagation of
spontaneous retinal waves. Science 272, 1182–1187 (1996).
34. Ackman, J. B., Burbridge, T. J. & Crair, M. C. Retinal waves coordinate
patterned activity throughout the developing visual system. Nature 490,
219–225 (2012).
35. Davis, Z. W., Sun, C., Derieg, B., Chapman, B. & Cheng, H.-J. Epibatidine
blocks eye-specific segregation in ferret dorsal lateral geniculate nucleus
during stage III retinal waves. PLoS ONE 10, e0118783 (2015).
36. Penn, A. A., Riquelme, P. A., Feller, M. B. & Shatz, C. J. Competition in
retinogeniculate patterning driven by spontaneous activity. Science 279,
2108–2112 (1998).
37. Chandrasekaran, A. R., Plas, D. T., Gonzalez, E. & Crair, M. C. Evidence for
an instructive role of retinal activity in retinotopic map refinement in the
superior colliculus of the mouse. J. Neurosci. 25, 6929–6938 (2005).
38. Pfeiffenberger, C. et al. Ephrin-As and neural activity are required for eye-
specific patterning during retinogeniculate mapping. Nat. Neurosci. 8,
1022–1027 (2005).
39. Rossi, F. M. et al. Requirement of the nicotinic acetylcholine receptor beta
2 subunit for the anatomical and functional development of the visual system.
Proc. Natl Acad. Sci. USA 98, 6453–6458 (2001).
40. Slaughter, M. M. & Miller, R. F. 2-amino-4-phosphonobutyric acid: a new
pharmacological tool for retina research. Science 211, 182–185 (1981).
41. Shiells, R. A., Falk, G. & Naghshineh, S. Action of glutamate and aspartate
analogues on rod horizontal and bipolar cells. Nature 294, 592–594 (1981).
42. Chapman, B. Necessity for afferent activity to maintain eye-specific
segregation in ferret lateral geniculate nucleus. Science 287, 2479–2482 (2000).
43. Nitta, T. et al. Size-selective loosening of the blood-brain barrier in claudin-5-
deficient mice. J. Cell Biol. 161, 653–660 (2003).
44. Kurihara, T., Westenskow, P. D. & Friedlander, M. Hypoxia-inducible factor
(HIF)/vascular endothelial growth factor (VEGF) signaling in the retina. Adv.
Exp. Med. Biol. 801, 275–281 (2014).
45. Daneman, R. et al. Wnt/β-catenin signaling is required for CNS, but not non-
CNS, angiogenesis. Proc. Natl Acad. Sci. 106, 641–646 (2009).
46. Liebner, S. et al. Wnt/β-catenin signaling controls development of the
blood–brain barrier. J. Cell Biol. 183, 409–417 (2008).
47. Stenman, J. M. et al. Canonical Wnt signaling regulates organ-specific assembly
and differentiation of CNS vasculature. Science 322, 1247–1250 (2008).
48. Lim, J. C. et al. Activation of beta-catenin signalling by GSK-3 inhibition
increases p-glycoprotein expression in brain endothelial cells. J. Neurochem.
106, 1855–1865 (2008).
49. Lim, J. C. et al. Decreased expression of multidrug efflux transporters in the
brains of GSK-3beta transgenic mice. Brain Res. 1276, 1–10 (2009).
50. Riganti, C. et al. Temozolomide down-regulates P-glycoprotein in human
blood–brain barrier cells by disrupting Wnt3 signaling. Cell. Mol. Life Sci. 71,
499–516 (2014).
51. Ramirez, S. H. et al. Inhibition of glycogen synthase kinase 3β promotes tight
junction stability in brain endothelial cells by half-life extension of occludin
and claudin-5. PLoS ONE 8, e55972 (2013).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10219-8 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2477 | https://doi.org/10.1038/s41467-019-10219-8 | www.nature.com/naturecommunications 9
52. Lengfeld, J. E. et al. Endothelial Wnt/β-catenin signaling reduces immune cell
infiltration in multiple sclerosis. Proc. Natl Acad. Sci. USA 114, E1168–E1177
(2017).
53. Wang, Y. et al. Norrin/Frizzled4 signaling in retinal vascular development and
blood brain barrier plasticity. Cell 151, 1332–1344 (2012).
54. Ye, X. et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells
controls a genetic program for retinal vascularization. Cell 139, 285–298
(2009).
55. Wang, Z. et al. Pharmacologic activation of Wnt signaling by lithium
normalizes retinal vasculature in a murine model of familial exudative
vitreoretinopathy. Am. J. Pathol. 186, 2588–2600 (2016).
56. Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest.
Ophthalmol. Vis. Sci. 35, 101–111 (1994).
57. Tauchi, M. & Masland, R. H. The shape and arrangement of the cholinergic
neurons in the rabbit retina. Proc. R. Soc. Lond. B Biol. Sci. 223, 101–119 (1984).
58. Wen, Q. & Chklovskii, D. B. A cost-benefit analysis of neuronal morphology.
J. Neurophysiol. 99, 2320–2328 (2008).
59. Blankenship, A. G. et al. Synaptic and extrasynaptic factors governing
glutamatergic retinal waves. Neuron 62, 230–241 (2009).
60. Paes, K. T. et al. Frizzled 4 is required for retinal angiogenesis and
maintenance of the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 52,
6452–6461 (2011).
61. Rattner, A., Wang, Y., Zhou, Y., Williams, J. & Nathans, J. The role of the
hypoxia response in shaping retinal vascular development in the absence of
Norrin/Frizzled4 signaling. Invest. Ophthalmol. Vis. Sci. 55, 8614–8625 (2014).
62. Usui, Y. et al. Neurovascular crosstalk between interneurons and capillaries is
required for vision. J. Clin. Invest. 125, 2335–2346 (2015).
63. Rosa, J. M. et al. Neuron-glia signaling in developing retina mediated by
neurotransmitter spillover. Elife 4, e09590 (2015). https://doi.org/10.7554/
eLife.09590.
Acknowledgements
Geoffrey Weiner was supported by the San Diego Foundation Blasker-Rose-Miah Science
and Technology Grant. Jeffrey Goldberg was supported by the Glaucoma Research
Foundation and Research to Prevent Blindness, as well as NEI P30-EY026877. Robert
Pulido was supported by a UCSD Cellular and Molecular Pharmacology Training Grant
from the National Institute of General Medical Sciences, T32 GM007752. Richard
Daneman was supported by NIH/NINDS R01 NS091281. This work was supported by
the Waitt Advanced Biophotonics Core Facility of the Salk Institute with funding from
NIH-NCI CCSG: P30 014195, NINDS Neuroscience Core Grant: NS072031 and the
Waitt Foundation. Thanks to Mari Gantner for assistance in learning the Seahorse XFe96
assays, Napoleone Ferrara and Cuiling Zhong for performing the BREC proliferation
assay, Joseph Miller for processing tissue sections, and Minjin Ju for immunofluorescence
staining.
Author contributions
This study was conceived by G.A.W. and J.L.G. Experimental design was done by
G.A.W., S.H.S., E.N., R.D. and J.L.G. Acquisition of data was by G.A.W., S.H.S., C.M.A.,
A.B.B. and R.S.P. Analysis and interpretation of data were done by G.A.W., S.H.S., A.M.,
E.N., R.D. and J.L.G. Drafting of the paper was done by G.A.W. and S.H.S. Revision of
the paper was done by G.A.W., S.H.S., E.N., R.D. and J.L.G.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-10219-8.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Journal peer review information: Nature Communications thanks Britta Engelhardt and
other anonymous reviewer(s) for their contribution to the peer review of this work.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10219-8
10 NATURE COMMUNICATIONS |         (2019) 10:2477 | https://doi.org/10.1038/s41467-019-10219-8 | www.nature.com/naturecommunications
